Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aethlon Medical Inc AEMD

Aethlon Medical, Inc. is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device which is designed to combat cancer and life-threatening viral infections and for use in organ transplantation. The Hemopurifier, in pre-clinical studies, has demonstrated the removal of harmful exosomes from biological fluids, utilizing its lectin-based... see more

Recent & Breaking News (NDAQ:AEMD)

/C O R R E C T I O N -- Aethlon Medical, Inc./

PR Newswire May 24, 2022

Aethlon Medical to Present at the H.C. Wainwright Global Investment Conference

PR Newswire May 17, 2022

Aethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 Variants

PR Newswire May 2, 2022

Aethlon Medical, Inc. Appoints Angela Rossetti to Board of Directors

PR Newswire March 28, 2022

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

PR Newswire February 14, 2022

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 14, 2022

PR Newswire January 31, 2022

Aethlon Medical Announces Second Quarter Financial Results and Provides Corporate Update

PR Newswire November 9, 2021

Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 9, 2021

PR Newswire November 2, 2021

Aethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated with the Hemopurifier®

PR Newswire October 12, 2021

Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs

PR Newswire September 30, 2021

Aethlon Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

PR Newswire September 7, 2021

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

PR Newswire August 9, 2021

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2021

PR Newswire July 29, 2021

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

PR Newswire June 24, 2021

Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021

PR Newswire June 21, 2021

Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

PR Newswire June 10, 2021

Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier®

PR Newswire June 3, 2021

Aethlon Medical to Participate in Two Upcoming Healthcare Investor Conferences

PR Newswire March 1, 2021

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

PR Newswire February 10, 2021

Aethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 10, 2021

PR Newswire February 4, 2021